Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H18ClNO4 |
| Molecular Weight | 347.793 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)N(CCCC(O)=O)C(=O)C2=CC=C(Cl)C=C2
InChI
InChIKey=VUPBWNXFSDRWJE-UHFFFAOYSA-N
InChI=1S/C18H18ClNO4/c1-24-16-10-8-15(9-11-16)20(12-2-3-17(21)22)18(23)13-4-6-14(19)7-5-13/h4-11H,2-3,12H2,1H3,(H,21,22)
Clanobutin is a choleretic drug. It increases the secretion of bile by hepatocytes. Clanobutin sodium has been introduced as a choleretic and digestant agent for animals. It has been used in all domestic animals in which enhancement of digestion and all associated secretory processes are indicated. Clanobutin was reported to induce a demonstrable increase in the secretory activity of the exocrine digestive glands and in the excretion of the bile.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA16QA05
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
||
|
NCI_THESAURUS |
C66913
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB06639MIG
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
3104
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
W6Y945055S
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
100000080169
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
DTXSID10184628
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
m3607
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
250-232-3
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
C77837
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
2907
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
35378
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107589
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
30544-61-7
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY | |||
|
C019159
Created by
admin on Fri Dec 15 16:02:10 GMT 2023 , Edited by admin on Fri Dec 15 16:02:10 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
